Standard BioTools Inc. (LAB) vs Shoulder Innovations, Inc. (SI)
Standard BioTools Inc. and Shoulder Innovations, Inc. are both Medical Devices companies. Shoulder Innovations, Inc. is the larger, with a market value of $354.1M against $291.7M — 1.2× the size. Shoulder Innovations, Inc. has negative trailing earnings, so its P/E is not meaningful; Standard BioTools Inc. trades at 3.4×. Shoulder Innovations, Inc. grew revenue faster over the last twelve months: 62.9% against 30.2%. Standard BioTools Inc. has the higher net margin (100.4% vs −58.3%) and the lower return on invested capital (−93.9% vs −54.7%). Across the 17 metrics below, Standard BioTools Inc. leads on 9 and Shoulder Innovations, Inc. on 8.
Valuation
Profitability
| Metric | LAB | SI | Medical Devices median |
|---|---|---|---|
| Gross margin | 50.49% | 77.34% | 56.01% |
| Operating margin | (112.85%) | (58.53%) | (15.03%) |
| Net margin | 100.37% | (58.33%) | (20.40%) |
| Free cash flow margin | (97.61%) | (78.39%) | (7.24%) |
| Return on equity | 17.61% | (151.89%) | (15.32%) |
| Return on assets | 14.34% | (30.49%) | (19.72%) |
| Return on invested capital | (93.89%) | (54.72%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack